Anzahl der Einträge: 12.
2023
Fante, Matthias A.,
Harrer, Dennis C. ,
Zartner, Barbara,
Lüke, Florian ,
Mayer, Stephanie,
Menhart, Karin ,
Reichle, Albrecht ,
Herr, Wolfgang,
Vogelhuber, Martin und
Heudobler, Daniel
(2023)
All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma.
Frontiers in Oncology 13.
2022
Harrer, Dennis Christoph ,
Denk, Alexander,
Keil, Felix,
Menhart, Karin,
Mayer, Stephanie,
Wolff, Daniel,
Edinger, Matthias,
Herr, Wolfgang und
Grube, Matthias
(2022)
Unusually swift response of relapsed Burkitt leukemia to R‐DHAP.
eJHaem 3 (3), S. 1003-1008.
Heudobler, Daniel,
Fante, Matthias A.,
Felsensteiner, Mona,
Mayer, Stephanie,
Gerken, Michael,
Klinkhammer-Schalke, Monika,
Herr, Wolfgang,
Vogelhuber, Martin und
Reichle, Albrecht
(2022)
All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma.
Frontiers in Oncology 2022 (12), S. 1-11.
Steinhelfer, Lisa,
Kühnel, Thomas S. ,
Jägle, Herbert ,
Mayer, Stephanie,
Karrer, Sigrid ,
Haubner, Frank und
Schreml, Stephan
(2022)
Systemic therapy of necrobiotic xanthogranuloma: a systematic review.
Orphanet Journal of Rare Diseases 17, art.no.132.
Houot, Roch,
Poeschel, Viola,
Altmann, Bettina,
Angel, Stephanie,
Thurner, Lorenz,
Illmer, Thomas,
Andre, Marc,
Dreyling, Martin,
Maisonneuve, Hervé,
Tilly, Hervé,
Mayer, Stephanie,
Casasnovas, Olivier ,
Le Gouill, Steven,
Offner, Fritz,
Cartron, Guillaume,
Kerkhoff, Andrea,
Weber, Thomas,
Hoffmann, Joerg,
Ziepert, Marita,
Klapper, Wolfram,
Itti, Emmanuel,
Hellwig, Dirk ,
Natchkebia, Giorgi,
de Leval, Laurence,
Rosenwald, Andreas,
Haioun, Corinne,
Dercle, Laurent,
Gaulard, Philippe und
Held, Gerhard
(2022)
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.
HemaSphere 6 (2), e672.
Volltext nicht vorhanden.
2021
Liebers, Nora,
Duell, Johannes,
Fitzgerald, Donnacha,
Kerkhoff, Andrea,
Noerenberg, Daniel,
Kaebisch, Eva,
Acker, Fabian,
Fuhrmann, Stephan,
Leng, Corinna,
Welslau, Manfred,
Chemnitz, Jens,
Middeke, Jan-Moritz,
Weber, Thomas,
Holtick, Udo,
Trappe, Ralf,
Pfannes, Roald,
Liersch, Ruediger,
Spoer, Christian,
Fuxius, Stefan,
Gebauer, Niklas,
Caillé, Léandra,
Geer, Thomas,
Koenecke, Christian,
Keller, Ulrich,
Claus, Rainer,
Mougiakakos, Dimitrios,
Mayer, Stephanie,
Huettmann, Andreas,
Pott, Christiane,
Trummer, Arne,
Wulf, Gerald,
Brunnberg, Uta,
Bullinger, Lars,
Hess, Georg,
Mueller-Tidow, Carsten,
Glass, Bertram,
Lenz, Georg,
Dreger, Peter und
Dietrich, Sascha
(2021)
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas.
Blood Advances 5 (13), S. 2707-2716.
Volltext nicht vorhanden.
2020
Harrer, Dennis Christoph,
Menhart, Karin,
Mayer, Stephanie,
Herr, Wolfgang,
Reichle, Albrecht und
Vogelhuber, Martin
(2020)
Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report.
Frontiers in Oncology 10 (585830), S. 1-4.
2017
Hierl, Marina,
Pfirstinger, Jochen,
Andreesen, Reinhard,
Holler, Ernst,
Mayer, Stephanie,
Wolff, Daniel und
Vogelhuber, Martin
(2017)
Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients.
Oncology 93 (3), S. 157-163.
Volltext nicht vorhanden.
2002
Krause, Stefan W.,
Neumann, Christine,
Soruri, Afasaneh,
Mayer, Stephanie,
Peters, J. Hinrich und
Andreesen, Reinhard
(2002)
The Treatment of Patients With Disseminated Malignant Melanoma by Vaccination With Autologous Cell Hybrids of Tumor Cells and Dendritic Cells.
Journal of Immunotherapy 25 (5), S. 421-428.
Volltext nicht vorhanden.
Krause, Stefan W.,
Neumann, Christine,
Soruri, Afasaneh,
Mayer, Stephanie,
Peters, J. Hinrich und
Andreesen, Reinhard
(2002)
The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells.
Journal of immunotherapy 25 (5), S. 421-8.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Thu Jan 9 20:17:47 2025 CET.